Literature DB >> 18362797

Quantifying postoperative bone loss in children.

Elizabeth A Szalay1, Debra Harriman, Brittany Eastlund, Deana Mercer.   

Abstract

BACKGROUND: Postoperative bone density loss is an accepted phenomenon that has not been objectively quantified. The extent of this bone loss is documented using preoperative and postoperative dual energy x-ray absorptiometry scans to demonstrate the magnitude of the problem and to underline the need for prevention and treatment.
METHODS: Children undergoing lower extremity surgery who required a minimum of 4 weeks of either non-weight bearing or cast immobilization postoperatively were recruited to undergo preoperative and postoperative dual energy x-ray absorptiometry scans of lumbar spine and both distal femora. Percent change in bone mineral density (BMD) as well as Z-scores in preoperative and postoperative scans were compared, as were operated and nonoperated limbs, using paired t tests.
RESULTS: Fifteen of 18 subjects completed the second scan. Children lost up to 34% BMD in the cancellous region of the operated leg (average, 16.5%), up to 28% in transitional bone (average, 11.5%), and up to 16% (average, 4.8%) in the cortical region (P < 0.05). The Z-scores fell 1.0 SD for cancellous, 0.75 transitional, and 0.45 cortical.
CONCLUSIONS: That children can lose up to 34% of BMD in 4 to 6 weeks is sobering. A 1 SD drop in T score, in adults, can infer a 2-fold increase in fracture risk. This may be insignificant in a healthy child with good BMD, but to a chronically ill child, a doubling of fracture risk may lead to insufficiency fracture. Avoiding the problem and proactive treatment are the goals. LEVEL OF EVIDENCE: Level I, prospective diagnostic study.

Entities:  

Mesh:

Year:  2008        PMID: 18362797     DOI: 10.1097/BPO.0b013e318168c75e

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  7 in total

Review 1.  The Utility of DXA Assessment at the Forearm, Proximal Femur, and Lateral Distal Femur, and Vertebral Fracture Assessment in the Pediatric Population: 2019 ISCD Official Position.

Authors:  David R Weber; Alison Boyce; Catherine Gordon; Wolfgang Högler; Heidi H Kecskemethy; Madhusmita Misra; Diana Swolin-Eide; Peter Tebben; Leanne M Ward; Halley Wasserman; Christopher Shuhart; Babette S Zemel
Journal:  J Clin Densitom       Date:  2019-07-10       Impact factor: 2.617

2.  Fixation of subtrochanteric extending/derotational femoral osteotomies with the Locking Compression Plate in ambulatory neuro-orthopaedic patients.

Authors:  Mathias Haefeli; Hanspeter Huber; Stefan Dierauer; Leonhard E Ramseier
Journal:  J Child Orthop       Date:  2010-08-01       Impact factor: 1.548

3.  Decrease of physical activity level in adolescents with limb fractures: an accelerometry-based activity monitor study.

Authors:  Dimitri Ceroni; Xavier Martin; Cécile Delhumeau; Nathalie Farpour-Lambert
Journal:  BMC Musculoskelet Disord       Date:  2011-05-04       Impact factor: 2.362

4.  The outcome of paediatric LCP hip plate use in children with and without neuromuscular disease.

Authors:  S U Islam; A Henry; T Khan; N Davis; M Zenios
Journal:  Musculoskelet Surg       Date:  2013-12-03

5.  Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients.

Authors:  Carsten Müller; Corinna C Winter; Dieter Rosenbaum; Joachim Boos; Georg Gosheger; Jendrik Hardes; Volker Vieth
Journal:  BMC Musculoskelet Disord       Date:  2010-12-29       Impact factor: 2.362

6.  Single-leg spica provides adequate stability after open reduction in developmental dysplasia of the hip.

Authors:  Nabil Alassaf
Journal:  Arch Orthop Trauma Surg       Date:  2017-11-16       Impact factor: 3.067

7.  Femur shaft fracture at a young age and the risk of subsequent severe injuries during childhood: a cohort study.

Authors:  Johan von Heideken; Tobias Svensson; Maura Iversen; Anders Ekbom; Per-Mats Janarv
Journal:  BMC Pediatr       Date:  2014-03-03       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.